Gilead Sciences, Inc. (GILD) operating KPIs
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)
Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%
Gilead Sciences total HCV Franchise (legacy sub-franchise breakout) — Worldwide YoY growth (%) (%)
Form 8-K Total Revenue Summary
Latest, Q4 2022
12.0%
Period ended Dec 31, 2022
Change on a year earlier
+19.0 pts
-7.0% in Q4 2021
History
8 quarters
Since Q1 2021
Sources
8
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total HCV Franchise (legacy sub-franchise breakout) — Worldwide YoY growth (%) (%) | Year on year | Source |
|---|---|---|---|---|
| Q4 2022 | Dec 31, 2022 | 12.0% | +19.0 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| Q3 2022 | Sep 30, 2022 | 22.0% | +30.0 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2022-10-27) ↗ |
| Q2 2022 | Jun 30, 2022 | -18.0% | -41.0 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | -22.0% | +8.0 pts | Form 8-K (exhibit991earningspressrel.htm, filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | -7.0% | – | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
| Q3 2021 | Sep 30, 2021 | -8.0% | – | Form 8-K (exhibit991earningspressrel.htm, filed 2021-10-28) ↗ |
| Q2 2021 | Jun 30, 2021 | 23.0% | – | Form 8-K (exhibit991earningspressrel.htm, filed 2021-07-29) ↗ |
| Q1 2021 | Mar 31, 2021 | -30.0% | – | Form 8-K (exhibit991earningspressrel.htm, filed 2021-04-29) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Total HCV Franchise (legacy sub-franchise breakout) — Worldwide YoY growth (%) (%), quarterly Q1 2021–Q4 2022 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/liver_hcv_total_yoy
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.